7.4 Dementias, Normal Pressure Hydrocephalus & Neuro Pain Syndromes

Dementia, Hydrocephalus & Chronic Pain Syndromes

Dementia and Alzheimer's Disease

Dementia represents a broad spectrum of progressive neurocognitive disorders characterized by an insidious decline in memory, executive functioning, language, and behavior that is severe enough to severely interfere with daily life and independent functioning. Alzheimer's Disease (AD) is the most prevalent etiology, accounting for over 60-80% of all dementia cases. The pathophysiology of Alzheimer's Disease is defined by the extracellular accumulation of amyloid-beta plaques and the intracellular formation of neurofibrillary tangles composed of hyperphosphorylated tau protein. These toxic protein aggregates cause profound neuroinflammation, synaptic dysfunction, and widespread neuronal death, initially localizing in the hippocampus (devastating short-term memory) before spreading throughout the cerebral cortex. Pharmacological management for AD does not alter the underlying disease process but aims to temporarily stabilize symptoms. Cholinesterase inhibitors (e.g., donepezil, rivastigmine, galantamine) are utilized in mild to moderate disease to increase cholinergic transmission, while memantine, an NMDA receptor antagonist, is used in moderate to severe stages to block excitotoxic effects of glutamate. Nursing care for dementia patients is incredibly demanding and centers on maintaining a safe, structured, and profoundly calm environment. Interventions include strict implementation of fall precautions, utilizing bed and chair alarms, maintaining consistent daily routines, using clear and simple communication strategies, and aggressively preventing caregiver burnout through social work collaboration and respite care.

Normal Pressure Hydrocephalus (NPH)

Normal Pressure Hydrocephalus (NPH) is a critical, potentially reversible neurological syndrome that is frequently misdiagnosed as Alzheimer's disease or Parkinson's disease due to its overlapping clinical presentation. NPH is characterized by the abnormal accumulation of cerebrospinal fluid (CSF) leading to the massive enlargement of the cerebral ventricles, yet paradoxically, the intracranial pressure measured during a lumbar puncture typically remains within the high-normal range. The classic clinical presentation of NPH is famously defined by the NPH triad: gait ataxia, urinary incontinence, and dementia (often remembered by the mnemonic "wobbly, wet, and wacky"). The gait disturbance is usually the first and most prominent symptom, presenting as a magnetic, shuffling, or broad-based "glued to the floor" appearance. The dementia is typically frontal-subcortical, characterized by profound psychomotor slowing, extreme apathy, and significant executive dysfunction, rather than the primary memory loss seen in Alzheimer's. Urinary incontinence typically presents late in the disease process as urge incontinence due to detrusor hyperreflexia caused by stretched periventricular nerve fibers.

Diagnosis and Surgical Management of NPH

The diagnosis of NPH requires a high index of clinical suspicion. Neuroimaging, specifically an MRI or CT scan of the brain, will reveal massively enlarged ventricles (ventriculomegaly) disproportionate to the degree of cerebral atrophy. To confirm the diagnosis and determine the patient's potential response to definitive surgical treatment, a large-volume lumbar puncture, known as a tap test, is performed. During a tap test, 30 to 50 mL of CSF is deliberately removed, and the patient's gait and cognitive function are rigorously evaluated before and immediately after the procedure. A significant, objective improvement in gait velocity and stride length following the CSF removal strongly predicts a favorable surgical outcome. The definitive treatment for NPH is the surgical placement of a Ventriculoperitoneal (VP) shunt. This highly specialized catheter system drains the excess cerebrospinal fluid from the lateral ventricles of the brain directly into the peritoneal cavity of the abdomen, where it is harmlessly absorbed into the bloodstream. Postoperative nursing care demands extreme vigilance for complications such as shunt infection, mechanical obstruction, over-drainage (which can cause life-threatening subdural hematomas), and under-drainage (resulting in the return of the triad symptoms).

Chronic Pain Syndromes: Trigeminal Neuralgia

Trigeminal neuralgia (Tic Douloureux) is a debilitating, excruciating chronic pain syndrome affecting the fifth cranial nerve (CN V). The pathophysiology typically involves microvascular compression of the trigeminal nerve root—most often by the superior cerebellar artery—as it exits the brainstem. This constant pulsatile compression leads to focal demyelination and ectopic firing of the nerve fibers. Clinically, patients experience sudden, severe, unilateral, electric shock-like or stabbing facial pain along the distribution of the ophthalmic (V1), maxillary (V2), or mandibular (V3) branches of the trigeminal nerve. The pain is notoriously triggered by entirely innocuous stimuli, such as a light touch, chewing, talking, brushing teeth, or even a cold breeze on the face. Consequently, patients may refuse to eat, speak, or perform basic oral hygiene, leading to profound weight loss, severe dehydration, and immense psychological distress, including high rates of suicidal ideation due to the excruciating nature of the pain.

Management of Trigeminal Neuralgia

The first-line pharmacological treatment for trigeminal neuralgia is the anticonvulsant medication carbamazepine. It dramatically decreases the excitability of the neurons, providing significant pain relief for the majority of patients. Nurses must actively monitor for severe side effects of carbamazepine, including aplastic anemia, agranulocytosis, and Stevens-Johnson syndrome, necessitating routine complete blood counts and dermatological assessments. Other medications include oxcarbazepine, gabapentin, and baclofen. If pharmacological management fails or causes intolerable side effects, surgical interventions are aggressively pursued. The most definitive surgical procedure is microvascular decompression (MVD), a craniotomy in which the offending blood vessel is physically separated from the trigeminal nerve, and a small Teflon sponge is permanently placed between them. Nursing care for trigeminal neuralgia focuses intensely on pain management and identifying individual triggers. Care plans must include providing soft diets at room temperature, using extremely soft-bristled toothbrushes, avoiding directly touching the affected side of the face during assessments, and providing immense emotional support.